These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37936709)

  • 101. Relationship between glucocorticoids and viral load during the Omicron wave in mainland China.
    Bai G; Li Y; Liu Y; Wang X; Yu X; Ren L; Xu J
    Virol J; 2023 Nov; 20(1):273. PubMed ID: 37993863
    [TBL] [Abstract][Full Text] [Related]  

  • 102. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
    Bange EM; Han NA; Wileyto P; Kim JY; Gouma S; Robinson J; Greenplate AR; Porterfield F; Owoyemi O; Naik K; Zheng C; Galantino M; Weisman AR; Ittner CAG; Kugler EM; Baxter AE; Oniyide O; Agyekum RS; Dunn TG; Jones TK; Giannini HM; Weirick ME; McAllister CM; Babady NE; Kumar A; Widman AJ; DeWolf S; Boutemine SR; Roberts C; Budzik KR; Tollett S; Wright C; Perloff T; Sun L; Mathew D; Giles JR; Oldridge DA; Wu JE; Alanio C; Adamski S; Garfall AL; Vella L; Kerr SJ; Cohen JV; Oyer RA; Massa R; Maillard IP; ; Maxwell KN; Reilly JP; Maslak PG; Vonderheide RH; Wolchok JD; Hensley SE; Wherry EJ; Meyer N; DeMichele AM; Vardhana SA; Mamtani R; Huang AC
    Res Sq; 2021 Feb; ():. PubMed ID: 33564756
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Study on the correlation between lifestyle and negative conversion time in patients diagnosed with coronavirus disease (COVID-19): a retrospective cohort study.
    Li N; Liu C; Qiu L; Shen C; Zhang F; Lu Z; Zhou M; Sheng D; Liu Z
    BMC Public Health; 2023 Dec; 23(1):2410. PubMed ID: 38049851
    [TBL] [Abstract][Full Text] [Related]  

  • 104. CD4
    Eryılmaz-Eren E; Köker MY; Ulu-Kılıç A; Hürmet-Öz HT; Ay-Altıntop Y; Saatçi E; Özsoy S; Kılınç-Toker A; Topaloğlu US; Yüksel RC; Avcılar H; Beştepe-Dursun Z; Çelik İ
    Infect Dis Clin Microbiol; 2023 Mar; 5(1):23-30. PubMed ID: 38633909
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet-lymphocyte and low platelet-neutrophil aggregates.
    Maiorca F; Lombardi L; Marrapodi R; Pallucci D; Sabetta A; Zingaropoli MA; Perri V; Flego D; Romiti GF; Corica B; Miglionico M; Russo G; Pasculli P; Ciardi MR; Mastroianni CM; Ruberto F; Pugliese F; Pulcinelli F; Raparelli V; Cangemi R; Visentini M; Basili S; Stefanini L
    Res Pract Thromb Haemost; 2023 Nov; 7(8):102262. PubMed ID: 38193050
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Correlative factors of poor prognosis and abnormal cellular immune function in patients with Alzheimer's disease.
    Bai H; Zeng HM; Zhang QF; Hu YZ; Deng FF
    World J Clin Cases; 2024 Feb; 12(6):1063-1075. PubMed ID: 38464932
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Immune inhibitory receptor-mediated immune response, metabolic adaptation, and clinical characterization in patients with COVID-19.
    An H; Yan C; Ma J; Gong J; Gao F; Ning C; Wang F; Zhang M; Li B; Su Y; Liu P; Wei H; Jiang X; Yu Q
    Sci Rep; 2023 Nov; 13(1):19221. PubMed ID: 37932287
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Reporting of biochemical blood values in COVID-19 patients: A retrospective study.
    Eriten B; Eriten S
    Medicine (Baltimore); 2023 Nov; 102(44):e35833. PubMed ID: 37933044
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Hypoparathyroidism-Retardation-Dysmorphism Syndrome due to a Variant in the Tubulin-Specific Chaperone E Gene as a Cause of Combined Immune Deficiency.
    David O; Kristal E; Ling G; Broides A; Hadad N; Shubinsky G; Nahum A
    J Clin Immunol; 2023 Feb; 43(2):350-357. PubMed ID: 36258138
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Effects of antivirals on patients with COVID-19 breakthrough.
    Pham HT; Mai-Phan TA; Truong-Nguyen KH; Tran MH
    BMC Infect Dis; 2024 Jan; 24(1):25. PubMed ID: 38166755
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients.
    Svanberg R; MacPherson C; Zucco A; Agius R; Faitova T; Andersen MA; da Cunha-Bang C; Gjærde LK; Møller MEE; Brooks PT; Lindegaard B; Sejdic A; Gang AO; Hersby DS; Brieghel C; Nielsen SD; Podlekareva D; Hald A; Bay JT; Marquart H; Lundgren J; Lebech AM; Helleberg M; Niemann CU; Ostrowski SR
    Commun Med (Lond); 2022; 2():114. PubMed ID: 36101705
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Antibody Response to Breakthrough SARS-CoV-2 Infection in "Booster" Vaccinated Patients with Multiple Myeloma According to B/T/NK Lymphocyte Absolute Counts and anti-CD38 Treatments.
    Sgherza N; Mestice A; Larocca AMV; Musto P
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024022. PubMed ID: 38468827
    [No Abstract]   [Full Text] [Related]  

  • 113. Axes of Prognosis: Identifying Subtypes of COVID-19 Outcomes.
    Whitfield E; Coffey C; Zhang H; Shi T; Wu X; Li Q; Wu H
    AMIA Annu Symp Proc; 2021; 2021():1198-1207. PubMed ID: 35308999
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments.
    Loucera C; Carmona R; Esteban-Medina M; Bostelmann G; Muñoyerro-Muñiz D; Villegas R; Peña-Chilet M; Dopazo J
    Virol J; 2023 Oct; 20(1):226. PubMed ID: 37803348
    [TBL] [Abstract][Full Text] [Related]  

  • 115. COVID-19 with asthma: A case report.
    Liu AL; Xu N; Li AJ
    World J Clin Cases; 2020 Aug; 8(15):3355-3364. PubMed ID: 32874993
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions.
    Mathew D; Giles JR; Baxter AE; Greenplate AR; Wu JE; Alanio C; Oldridge DA; Kuri-Cervantes L; Pampena MB; D'Andrea K; Manne S; Chen Z; Huang YJ; Reilly JP; Weisman AR; Ittner CAG; Kuthuru O; Dougherty J; Nzingha K; Han N; Kim J; Pattekar A; Goodwin EC; Anderson EM; Weirick ME; Gouma S; Arevalo CP; Bolton MJ; Chen F; Lacey SF; Hensley SE; Apostolidis S; Huang AC; Vella LA; ; Betts MR; Meyer NJ; Wherry EJ
    bioRxiv; 2020 May; ():. PubMed ID: 32511371
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China.
    Li Y; Qiao S; Dong L; Zhang R; Li R; Qin S; Yu D; Liu X; Li Y; Ma Y; Zhao X; Gao GF
    Lancet Reg Health West Pac; 2023 Nov; 40():100945. PubMed ID: 38033432
    [No Abstract]   [Full Text] [Related]  

  • 118. Antibody tests suggest that coronavirus infections vastly exceed official counts.
    Mallapaty S
    Nature; 2020 Apr; ():. PubMed ID: 32303734
    [No Abstract]   [Full Text] [Related]  

  • 119. Correction to: Century of Milestones and Breakthroughs Related to the Immune Mechanisms of Atherosclerosis.
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):e209. PubMed ID: 38924444
    [No Abstract]   [Full Text] [Related]  

  • 120. How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study.
    Wang Y; Zhao B; Zhang X; Zhang X; Gao F; Yuan X; Ren X; Li M; Liu D
    Front Immunol; 2023; 14():1246751. PubMed ID: 37936709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.